Nonhematologic Neoplasms, Advanced
1 clinical trials · Condition
◉ Watch Nonhematologic Neoplasms, Advanced
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors (NCT02699749) | Millennium Pharmaceuticals, Inc. | 2016-03-24 |
Track Nonhematologic Neoplasms, Advanced automatically
Every clearance here is in the API, with alerts when new ones post.